• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bausch + Lomb Corporation Common Shares (NY: BLCO )

    17.97 -0.17 (-0.94%)
    Official Closing Price Updated: 4:00 PM EST, Dec 27, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Bausch + Lomb Corporation Common Shares

    < Previous 1 2 3 Next >
    Macy's, Dave & Buster's, Bausch + Lomb And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Deal Dispatch: Ubisoft In Buyout Talks, Dental Supplier Explores Sale, Beloved Drive-Through Goes Bankrupt
    Dental supply maker Patterson Companies Inc announced Thursday that it is exploring strategic options, including a sale or merger, to boost shareholder value. 
    Via Benzinga
    Topics Supply Chain
    Exposures Supply Chain
    Deal Dispatch: UFC, WWE Parent TKO Takes On Bull Riding; Endeavor Looks To Sell Tennis; Another Car Company Goes Bankrupt
    IMG tennis assets are on the auction block. The announcement came after TKO inked a deal with Endeavor for Professional Bull Riders. 
    Via Benzinga
    Deal Dispatch: Altus Power, Motorsport Games Explore Options, True Value Goes Bankrupt, M&A Activity Lags
    S&P Global's Joe Mantone puts the latest M&A data in perspective and how deal pros might react post-Election Day. 
    Via Benzinga
    Topics Bankruptcy Stocks
    Exposures Financial Legal US Equities
    Why Bausch + Lomb Rallied Today
    The highly indebted healthcare stock rose on rumors it may be selling itself. 
    Via The Motley Fool
    Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
    The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say following its July meeting. 
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    This Advance Auto Parts Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
    Via Benzinga
    Why Bausch + Lomb Stock Soared by Over 7% on Monday
    It was quite a busy and eventful day for the company. 
    Via The Motley Fool
    NVIDIA, Trump Media & Technology, Bausch + Lomb, Sirius XM And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Topics Government
    Exposures Political
    Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces
    Private equity giants TPG and Blackstone are pursuing a potential $14 billion buyout of Bausch + Lomb. 
    Via Benzinga
    Nike Reports Weak Sales, Joins Lamb Weston And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
    With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Barclays Maintains Equal-Weight Rating for Bausch & Lomb: Here's What You Need To Know
    Via Benzinga
    Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
    Federal Reserve's rate cut boosted tech, construction, industrial, machinery, and financial sectors. Top-performing mid-cap stocks last week. 
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues
    Bausch + Lomb is exploring a sale as its parent company, Bausch Health, faces significant debt and creditors' opposition to a spin-off. 
    Via Benzinga
    Topics Supply Chain
    Exposures Supply Chain
    Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It?
    Bausch + Lomb is reportedly considering a sale. But its potential acquirers could come up against antitrust concerns. 
    Via Investor's Business Daily
    Alcoa, Lattice Semiconductor, Stratasys And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Tech Stocks On Track For Best Session In 5 Months Ahead Of Fed Meeting; Small Caps Target Highest Close Since January 2022: What's Driving Markets Wednesday?
    Tech stocks soared to their best session in five months on Wednesday, ahead of the highly anticipated Federal Open Market Committee (FOMC) meeting. 
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Wall Street Remains On Track For AMD-Led Rebound Ahead Of Fed Decision, Meta Earnings: Analyst Says 'The Bull Tends To Remain' Despite Near-Time Volatility
    Tech optimism is likely to abound on Wall Street as AI-levered stocks are feeding off the strength generated by Advanced Micro Devices, Inc.‘s (NASDAQ:AMD) 
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Why Is Clearside Biomedical Stock Gaining Today?
    Clearside Biomedical pioneers suprachoroidal drug delivery for precise, effective treatment of retinal diseases. Oppenheimer rates CLSD Outperform with a $5 target, citing its innovative SCS... 
    Via Benzinga
    Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Do You Have Your Eye On Vision Care Stocks?
    For investors seeking stable and growing opportunities, eye care stocks are an attractive option. 
    Via Talk Markets
    American Airlines To Rally Around 59%? Here Are 10 Top Analyst Forecasts For Monday
    Via Benzinga
    BLCO Stock Earnings: Bausch & Lomb Meets EPS, Misses Revenue for Q1 2024
    BLCO stock results show that Bausch & Lomb met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Wall Street Set To Open Lower After AMD Earnings Disappoint As Traders Look To Fed's Powell For Relief: Why This Analyst Sees Incoming Summer Rally
    A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc.‘s (NASDAQ:AMD) 
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly... 
    Via Benzinga
    Eye Care-Focused Bausch + Lomb's Stock Surges On Upbeat Annual Guidance Despite Deeper Losses
    Bausch + Lomb achieves Q4 2023 sales of $1.173 billion, exceeding expectations with an 18% YoY growth. CEO Brent Saunders anticipates robust growth in 2024, projecting sales of $4.6-$4.7 billion and an... 
    Via Benzinga
    Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday
    U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Wall Street Waits With Bated Breath For Nvidia Earnings After Tech Selloff, Fed Minutes Eyed: Analyst Flags This As Biggest Risk For Market
    The market will broaden the sustenance of its rally when interest-rate cuts begin to be priced in and investors begin to think about the roadmap, an analyst said. 
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    < Previous 1 2 3 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.